Epidemiological, endocrine and metabolic features in Turner syndrome.
Turner syndrome is one of the more common genetic disorders, associated with abnormalities of the X chromosome, and occurring in about 50 per 100,000 liveborn girls. Turner syndrome is usually associated with reduced adult height, gonadal dysgenesis, and thus insufficient circulating levels of female sex steroids, and infertility. A number of other signs and symptoms are seen more frequent with the syndrome. Morbidity and mortality is increased. The average intellectual performance is within the normal range. With respect to epidemiology, cardiology, endocrinology and metabolism a number of recent studies have allowed new insight. Treatment with GH during childhood and adolescence allows a considerable gain in adult height. Puberty has to be induced in most cases, and female sex hormone replacement therapy is given during adult years. The proper dose of HRT has not been established, and, likewise, benefits and/or drawbacks from HRT has not been thoroughly evaluated. Since the risk of cardiovascular and endocrinological disease is clearly elevated, proper care during adulthood is emphasized. In summary, Turner syndrome is a condition associated with a number of disease and conditions which are reviewed in present paper.
Gravholt
Claus Højbjerg
CH
Medical Department, Aarhus University Hospital, Aarhus, Denmark. ch.gravholt@dadlnet.dk
D015519:Bone Density; D050260:Carbohydrate Metabolism; D005260:Female; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D008099:Liver / Q000503:physiopathology; D010053:Ovary / Q000503:physiopathology; D010902:Pituitary Gland / Q000503:physiopathology; D014424:Turner Syndrome / Q000150:complications / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology